Endocrine Society Names Kate Fryer as Chief Executive Officer

Fryer headshot

The Endocrine Society is excited to announce the selection of Kate Fryer as the organization’s next chief executive officer. Fryer has served in numerous scientific association leadership positions with deep experience in strategic planning, membership, scientific publishing, communications, society operations, as well as meetings and conferences.

“The year of COVID-19 was difficult for everyone, but our Society successfully pivoted when necessary, identified new solutions, and emerged stronger than it’s ever been,” says Endocrine Society President Gary D. Hammer, MD, PhD, of the University of Michigan in Ann Arbor. “Kate brings the perfect blend of leadership and association experience to not only build upon our momentum, but to propel us even further forward.”

Fryer comes to the Endocrine Society from the American Chemical Society (ACS) where she served as executive vice president, Membership & Society Services. Her focus was on modernizing their membership model and expanding and virtualizing their meetings and exposition portfolio. Prior to her position at ACS, Fryer was the deputy executive director at the Society for Neuroscience where she led the launch of their open-access journal as well as their online learning platform.

“It is an honor to serve as CEO for an organization so well-regarded for its long history of dedicated members and talented staff,” Fryer says. “This role will pair my passion for advancing and funding foundational research and the basic-to-translational-to-clinical continuum that the Endocrine Society so holistically embodies.”

“As Kate comes on board, it’s important to recognize the contributions of the interim CEO, Dr. Robert Lash,” says Society president-elect Carol Wysham, MD, clinical professor of medicine at the University of Washington. “Facing one of our most difficult years, Rob and the staff displayed remarkable nimbleness so that the pandemic would not hinder our mission to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide.”

Fryer will officially begin her role as chief executive officer on April 6.

PHOTO: Joe Shymanski at Joe Shymanski Photography

You may also like

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

  • New Position Statement Focuses on Patient Experience in Diabetes Care

    Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &…

Find more in